Seeing Is Believing
Currently out of the existing stock ratings of Navann Ty, 20 are a BUY (68.97%), 9 are a HOLD (31.03%).
Analyst Navann Ty, currently employed at BNP, carries an average stock price target met ratio of 48.15% that have a potential upside of 27.11% achieved within 191 days. Previously, Navann Ty worked at CITI.
Navann Ty’s has documented 58 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on OGN, Organon at 22-May-2025.
Analyst best performing recommendations are on ALKS (ALKERMES PLC).
The best stock recommendation documented was for ELAN (ELANCO ANIMAL HEALTH) at 10/1/2020. The price target of $32 was fulfilled within 6 days with a profit of $4.47 (16.24%) receiving and performance score of 27.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 29-Jun-2016
$2
$1.86 (1328.57%)
4 years 2 months 27 days ago
(09-May-2022)
6/7 (85.71%)
$0.8 (66.67%)
169
Sell Since 03-Mar-2022
$1
$0.86 (614.29%)
4 years 2 months 27 days ago
(09-May-2022)
3/3 (100%)
$-0.2 (-16.67%)
83
Hold Since 02-Mar-2022
$1
$0.86 (614.29%)
$3
4 years 2 months 30 days ago
(06-May-2022)
12/19 (63.16%)
$-0.42 (-29.58%)
91
Buy Since 24-Apr-2020
$6
$5.86 (4185.71%)
$11
4 years 4 months 27 days ago
(09-Mar-2022)
1/4 (25%)
$3.53 (142.91%)
250
Hold Since 09-Aug-2018
$17
4 years 9 months ago
(05-Nov-2021)
3/9 (33.33%)
$1.17 (7.39%)
101
What Year was the first public recommendation made by Navann Ty?